MAP2K7 and chronic myelogenous leukemia, BCR-ABL1 positive: Interestingly, Giotopoulos et al. identified potentially targetable pathways in CML such as ERG, MEK, RAF, JAK1/2, and confirmed that MYC is crucial for CML-progression to BC [50].